Wu, Jianqun
Huang, Songqiang
Yu, Yangyi
Lian, Qiang
Liu, Yang
Dai, Wenfeng
Liu, Qisong
Pan, Yonghao
Liu, Gui-ang
Li, Kai
Liu, Chao
Li, Guangheng https://orcid.org/0000-0001-6368-7071
Funding for this research was provided by:
National Natural Science Foundation of China (82172463)
Science, Technology and Innovation Commission of Shenzhen Municipality (KQTD20200820113012029)
Article History
Received: 19 February 2024
Accepted: 30 July 2024
First Online: 15 August 2024
Declarations
:
: The procedure for obtaining human tissue samples from hospitals was approved by the medical ethics committee of Shenzhen People’s Hospital (Approval Number: LL-KY-2021069; Title: Clinical investigation of mixed ADSCs and SDSCs for the treatment of human knee osteoarthritis by local joint injection; Date of approval: 01/03/2021). All the patients have signed informed consent forms for the use of the tissue samples. All experimental and animal care procedures were approved by Southern University of Science and Technology (Approval Number: SUSTech-SL2021112901; Title: The mechanism of combined human-derived ADSCs and SDSCs for the treatment of knee osteoarthritis, Date of approval: 12/01/2021).
: All authors have read and approved the final version of the manuscript.
: The authors declare no conflicts of financial interest.